In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, ...

When short sellers are betting heavily against a company, shareholders should exercise caution. At the top of the list is ...

A new study published in the Journal of Autism and Developmental Disorders suggests that the ability to comprehend complex ...

Ahead of the MTG Lorwyn Eclipsed January 2026 launch, Wizards of the Coast revealed a wealth of cards that players can expect ...

If you need to use specific software that doesn't have a native Linux version, then that's a pretty good reason not to use ...

His job is to reimagine the future of drugmaking using that similarly trendy branch of computer science, artificial ...

Here is the AI research roadmap for 2026: how agents that learn, self-correct, and simulate the real world will redefine ...

The strategic insertion of the past is no longer incidental in Bollywood films. It has become a deliberate trope in ...

A comprehensive quality control and assembly pipeline for VLP-enriched virome sequencing data generated from RdAB (Random displacement Amplification) protocol and Illumina NovaSeq sequencing. Raw ...

Author Shawn Peters blends clarity and rigor to make data structures and algorithms accessible to all learners. COLORADO, CO, UNITED STATES, January 2, 2026 /EINPresswire.com/ — Vibrant Publishers ...

This school year, all California State University students were given access to an educational version of ChatGPT, a ...